Evidence map›Paper›PMID 35274076›Full record

ArticleAllergologie select2022

S3 guideline Allergy Prevention.

Matthias V Kopp, Cathleen Muche-Borowski, Michael Abou-Dakn, Birgit Ahrens, Kirsten Beyer, Katharina Blümchen, Petra Bubel, Adam Chaker, Monika Cremer, Regina Ensenauer and 33 more

Open access · greenAbstract read
In one paragraph

Article in Allergologie select, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
20.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 102 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Pre-chewing for weaning: A traditional method for allergy prevention? Rationale, study design, and methods of the open-label trial-Solids-by-Kiss.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Treatment of Allergies to Fur Animals.International journal of molecular sciences · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

43 authors at 10 institutions in 3 countries.

Matthias V KoppAirway Research Center North, University of Lübeck, Member of Deutsches Zentrum für Lungenforschung, Universitätsklinik für Kinderheilkunde, Inselspital, Bern, Schweiz.
Cathleen Muche-BorowskiInstitut für Allgemeinmedizin, University Medical Center Hamburg-Eppendorf, Hamburg, Deutschland.
Michael Abou-DaknClinic for Gynecology and Obstetrics, St. Joseph-Krankenhaus Berlin-Tempelhof, Deutschland.
Birgit AhrensChildren's Hospital, University Hospital Frankfurt, Deutschland.
Kirsten BeyerDepartment of Pediatric Pneumology and Immunology, University Hospital Charite, Berlin, Deutschland.
Katharina BlümchenChildren's Hospital, University Hospital Frankfurt, Deutschland.
Petra BubelHNO-Facharztpraxis, Eisleben, Deutschland.
Adam ChakerHNO-Klinik, Klinikum rechts der Isar, Technical University of Munich, Munich, Deutschland.
Monika CremerÖkotrophologin, Journalistin, Idstein/Taunus, Deutschland.
Regina EnsenauerInstitut für Kinderernährung, Max Rubner-Institut, Karlsruhe, Deutschland.
Michael GerstlauerKinderklinik, Universitätsklinikum Augsburg, Deutschland.
Uwe GielerKlinik für Psychosomatik und Psychotherapie des UKGM, Universitätsklinik, Giessen, Deutschland.
Inga-Marie HübnerArbeitsgemeinschaft Dermatologiche Prävention e.V., Hamburg, Deutschland.
Fritz HorakAllergiezentrum Wien West, Wien, Österreich.
Ludger KlimekZentrum für Rhinologie und Allergologie, Wiesbaden, Deutschland.
Berthold V KoletzkoIntegriertes Sozialpädiatrisches Zentrum, Dr. von Haunerschen Kinderspital, LMU Klinikum der Universität München, München, Deutschland.
Sybille KoletzkoAbteilung für Stoffwechsel und Ernährung, Dr. von Haunersches Kinderspital, LMU Klinikum der Universität München, München, Deutschland.
Susanne LauDepartment of Pediatric Pneumology and Immunology, University Hospital Charite, Berlin, Deutschland.
Thomas Lob-CorziliusKinder- und Jugendmedizin, Christliches Kinderhospital Osnabrück, Deutschland.
Katja NematKinderzentrum Dresden-Friedrichstadt, Dresden, Deutschland.
Eva M J PetersKlinik für Psychosomatik und Psychotherapie des UKGM, Universitätsklinik, Giessen, Deutschland.
Antonio PizzulliSchwerpunktpraxis für Allergologie und Lungenheilkunde im Kinder- und Jugendalter, Berlin, Deutschland.
Imke ReeseErnährungsberatung und -therapie mit Schwerpunkt Allergologie, München, Deutschland.
Claudia Rolinck-WerninghausPraxis für Kinder- und Jugendmedizin, Berlin, Deutschland.
Elien RouwKinderarztpraxis, Bühl, Deutschland.
Bianca SchaubAsthma- und Allergieambulanz, Dr. von Haunersches Kinderspital, LMU Klinikum der Universität, München, Deutschland.
Sebastian SchmidtAllgemeine Pädiatrie, Klinik und Poliklinik für Kinder- und Jugendmedizin, Universitätsmedizin Greifswald, Greifswald, Deutschland.
Jens-Oliver SteißFacharztpraxis für Kinder- und Jugendmedizin, Fulda, Deutschland.
Anne Kathrin StriegelKinder- und Jugendmedizin, Universitätsklinikum, Köln, Deutschland.
Zsolt SzépfalusiUniversitätsklinik für Kinder- und Jugendheilkunde, Medizinische Universität Wien, Wien, Österreich.
Dietmar SchlembachKlinik für Geburtsmedizin, Vivantes Klinikum Neukölln, Berlin.
Thomas SpindlerHochgebirgsklinik Davos, Schweiz.
Christian TaubeKlinik für Pneumologie, Ruhrlandklinik, Westdeutsches Lungenzentrum am Universitätsklinikum, Essen, Deutschland.
Valérie TrendelenburgDepartment of Pediatric Pneumology and Immunology, University Hospital Charite, Berlin, Deutschland.
Regina TreudlerKlinik für Dermatologie, Venerologie und Allergologie, Leipziger Allergie-Centrum LICA - CAC, Universitätsmedizin, Leipzig, Deutschland.
Ulrich UmpfenbachPraxis für Kinder- und Jugendmedizin, Dülken, Deutschland.
Christian VogelbergKlinik und Poliklinik für Kinder- und Jugendmedizin, Universitätsklinikum Carl Gustav Carus an der Technischen Universität, Dresden, Deutschland.
Martin WagenmannHNO-Klinik, Universitätsklinikum Düsseldorf, Düsseldorf, Deutschland.
Anke WeißenbornGerman Federal Institute for Risk Assessment, Berlin, Deutschland.
Thomas WerfelKlinik für Dermatologie, Allergologie und Venerologie, Medizinische Hochschule Hannover, Hannover, Deutschland.
Margitta WormKlinik für Dermatologie, Allergologie und Venerologie, Campus Charité Mitte, Universitätsmedizin Berlin, Berlin, Deutschland.
Helmut SitterInstitut für Chirurgische Forschung, Philipps-Universität, Marburg, Deutschland, and.
Eckard HamelmannKinder-Zentrum Bethel, Evangelisches Klinikum Bethel, Universitätsklinik für Kinder- und Jugendmedizin, Universitätsklinikum OWL, Universität Bielefeld, Bielefeld, Deutschland.
Allergiezentrum Wien West · ATHeinrich Heine University Düsseldorf · DEHochgebirgsklinik Davos · CHKlinik und Poliklinik für Kinder- und Jugendmedizin · DEKrankenhaus Dresden-Friedrichstadt · DEMax Rubner Institut · DEMedical University of Vienna · ATMedizinische Hochschule Hannover · DEVivantes Klinikum · DEZentrum für Rhinologie und Allergologie · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe persistently high prevalence of allergic diseases in Western industrial nations and the limited possibilities of causal therapy make evidence-based recommendations for primary prevention necessary.

methodsThe recommendations of the S3 guideline Allergy Prevention, published in its last version in 2014, were revised and consulted on the basis of a current systematic literature search. The evidence search was conducted for the period 06/2013 - 11/2020 in the electronic databases Cochrane and MEDLINE, as well as in the reference lists of current reviews and through references from experts. The literature found was screened in two filtering processes, first by title and abstract, and the remaining papers were screened in the full text for relevance. The studies included after this were sorted by level of evidence, and the study quality was indicated in terms of potential bias (low/high). The revised recommendations were formally agreed and consented upon with the participation of representatives of the relevant professional societies and (self-help) organizations (nominal group process). Of 5,681 hits, 286 studies were included and assessed.

resultsRecommendations on maternal nutrition during pregnancy and breastfeeding as well as on infant nutrition in the first months of life again play an important role in the updated guideline: Many of the previous recommendations were confirmed by the current data. It was specified that breastfeeding should be exclusive for the first 4 - 6 months after birth, if possible, and that breastfeeding should continue with the introduction of complementary foods. A new recommendation is that supplementary feeding of cow's milk-based formula should be avoided in the first days of life if the mother wishes to breastfeed. Furthermore, it was determined that the evidence for a clear recommendation for hydrolyzed infant formula in non-breastfed infants at risk is currently no longer sufficient. It is therefore currently recommended to check whether an infant formula with proven efficacy in allergy prevention studies is available until the introduction of complementary feeding. Finally, based on the EAACI guideline, recommendations were made for the prevention of chicken egg allergy by introducing and regularly giving thoroughly heated (e.g., baked or hard-boiled) but not "raw" chicken egg (also no scrambled egg) with the complementary food. The recommendation to introduce peanut in complementary feeding was formulated cautiously for the German-speaking countries: In families who usually consume peanut, the regular administration of peanut-containing foods in age-appropriate form (e.g., peanut butter) with the complementary diet can be considered for the primary prevention of peanut allergy in infants with atopic dermatitis (AD). Before introduction, a clinically relevant peanut allergy must be ruled out, especially in infants with moderate to severe AD. There is still insufficient evidence for an allergy-preventive efficacy of prebiotics or probiotics, vitamin D, or other vitamins in the form of supplements so that recommendations against their supplementation were adopted for the first time in the current guideline. Biodiversity plays an important role in the development of immunological tolerance to environmental and food allergens: there is clear evidence that growing up on a farm is associated with a lower risk of developing asthma and allergic diseases. This is associated with early non-specific immune stimulation due to, among other things, the greater microbial biodiversity of house dust in this habitat. This aspect is also reflected in the recommendations on animal husbandry, on which a differentiated statement was made: In families without a recognizable increased allergy risk, pet keeping with cats or dogs should not generally be restricted. Families with an increased allergy risk or with children with already existing AD should not acquire a new cat - in contrast, however, dog ownership should not be discouraged. Interventions to reduce exposure to dust mite allergens in the home, such as the use of mite allergen-proof mattress covers ("encasings"), should be restricted to patients with already proven specific sensitization against house dust mite allergen. Children born by caesarean section have a slightly increased risk of asthma - this should be taken into account when advising on mode of delivery outside of emergency situations. Recent work also supports the recommendations on air pollutants: Active and passive exposure to tobacco smoke increase the risk of allergies, especially asthma, and should therefore be avoided. Exposure to nitrogen oxides, ozone, and small particles (PM 2.5) is associated with an increased risk, especially for asthma. Therefore, exposure to emissions of nitrogen oxides, ozone, and small particles (PM 2.5) should be kept low. The authors of this guideline are unanimously in favor of enacting appropriate regulations to minimize these air pollutants. There is no evidence that vaccinations increase the risk of allergies, but conversely there is evidence that vaccinations can reduce the risk of allergies. All children, including children at risk, should be vaccinated according to the current recommendations of the national public health institutes, also for reasons of allergy prevention.

conclusionThe consensus of recommendations in this guideline is based on an extensive evidence base. The update of the guideline enables evidence-based and up-to-date recommendations for the prevention of allergic diseases including asthma and atopic dermatitis.

Indexed as

allergyevidenceprimary preventionrevisionS3 guideline

Identifiers

PMID35274076
PMCPMC8905073
OpenAlexW4214947089

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.